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Abstract Rat 3-hydroxyisobutyrate dehydrogenase xhibits 
significant amino acid sequence homology with 6-phosphogluco- 
hate dehydrogenase, D-phenylserine dehydrogenase from Pseu- 
domonas syringae, and a number of hypothetical proteins 
encoded by genes of microbial origin. Key residues previously 
proposed to have roles in substrate binding and catalysis in sheep 
6-phosphogluconate d hydrogenase are highly conserved in this 
entire family of enzymes. Site-directed mutagenesis, chemical 
modification, and substrate specificity studies were used to 
compare possible mechanistic similarities of 3-hydroxyisobuty- 
rate dehydrogenase with 6-phosphoghiconate dehydrogenase. 
The data suggest hat 3-hydroxyisobutyrate and 6-phosphoglu- 
conate dehydrogenases may comprise, in part, a previously 
unrecognized family of 3-hydroxyacid ehydrogenases. 
Key words: Dehydrogenase; 3-Hydroxyisobutyrate; 
6-Phosphogluconate; Pyridoxal phosphate 
1. Introduction 
The catabolism of valine, unlike that of other branched- 
chain amino acids, occurs with the formation of a free 
branched-chain acid, (S)-3-hydroxyisobutyrate or HIBA, 
which is not metabolized as a coenzyme A thioester. HIBA 
is reversibly oxidized in mitochondria to methylmalonate 
semialdehyde bya highly specific, NAD+-dependent dehydro- 
genase (HIBADH or 3-hydroxy-2-methylpropionate:NAD + 
oxidoreductase, EC 1.1.1.31) [1]. Native rabbit liver HIBADH 
and recombinant rat HIBADH have been purified and char- 
acterized [2,3], as well as several HIBADH isoforms from 
microbial sources [4,5], and cDNA sequences have been re- 
ported for the rat liver and Pseudomonas eruginosa enzymes 
[6,7]. Previous studies of rat HIBADH tentatively placed the 
enzyme in the now well-established short-chain alcohol dehy- 
drogenase family. This assignment was based on amino acid 
sequence homology, effects of tyrosine-specific chemical mod- 
ification, and enzymatic properties such as the lack of a metal 
requirement for catalysis [3,8]. However, site-directed muta- 
genesis tudies indicated that HIBADH differs in mechanism 
from the short-chain dehydrogenases studied to date, such as 
Drosophila alcohol dehydrogenase, and, therefore, may in fact 
not be a member of the short-chain dehydrogenases [3]. In- 
deed, the short-chain dehydrogenases mostly prefer secondary 
alcohols as optimal substrates whereas HIBADH is only ac- 
tive with primary alcohol substrates. We now show that HI- 
BADH shares better amino acid sequence homology and en- 
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zymatic properties with a separate, previously unrecognized 
family of enzymes that includes 6-phosphogluconate dehydro- 
genase from numerous species, D-phenylserine d hydrogenase 
from P. syringae, and several hypothetical proteins of micro- 
bial origin. Like the short-chain dehydrogenases, these en- 
zymes have no requirement for divalent metal ions, and con- 
tain a highly conserved inucleotide cofactor-binding domain 
located at the N-terminus. However, the highly conserved 
sequence present in this domain differs from that of other 
dehydrogenases such as the short-chain dehydrogenases. The 
X-ray crystal structure of native sheep 6-phosphogluconate 
dehydrogenase was recently reported [9] and most of the ami- 
no acid residues uggested to be important for substrate bind- 
ing and catalysis from the crystallographic data are com- 
pletely conserved in all of the present sequences. Further- 
more, specific, conserved lysine and asparagine residues pro- 
posed to be of importance in the catalytic mechanism of 6- 
phosphogluconate dehydrogenase [9]are now shown by site- 
directed mutagenesis to be important for catalysis by HI- 
BADH. The present study suggests that 6-phosphogluconate 
dehydrogenase and HIBADH may share a common evolu- 
tionary origin and enzymatic mechanism. 
2. Materials and methods 
2.1. Materials 
The oligonucleotide-directed mutagenesis system and Escherichia 
coli strain TG1 were obtained from Amersham. The Sequenase 
DNA sequencing system was obtained from US Biochemicals. The 
plasmid pET28a+ and the E. coli strain HMS174(DE3) were pur- 
chased from Novagen. VCS-M13 helper phage was obtained from 
Stratagene. Nickel-NTA-agarose was purchased from Qiagen. Methyl 
esters of (S)- and (R)-3-hydroxy-2-propionate wer  purchased from 
Aldrich. (S)- and (R)-3-hydroxyisobutyrate ph nylethylamine salts 
were prepared as described previously [2]. All other chemicals were 
purchased from Sigma. 
2.2. Construction fpET-HIBADH expression vector and site-directed 
mutagenesis 
Rat HIBADH cDNA was excised from the previously described 
vector pGEX-HIBADH [3] by treatment with NdeI and HindlII 
and purified by agarose gel electrophoresis. This cDNA was ligated 
to the NdeI and HindlII sites of plasmid pET28a+ forming an expres- 
sion vector coding for HIBADH with a 5' 6-histidine tag fused in 
frame at the N-terminus. The fidelity of this construct was verified by 
dideoxynucleotide sequencing. Single stranded pET-HIBADH DNA 
was isolated using VCS-M13 helper phage as previously described [3]. 
Site-directed mutagenesis was performed according to the manufac- 
turer's protocol (Amersham). The fidelity of each mutant cDNA was 
confirmed by restriction analysis and double-stranded sequencing. For 
expression of wild-type and mutant HIBADHs, the corresponding 
plasmids were transformed into HMS174(DE3) E. coli and grown in 
TY media at 37°C until the absorbance at 600 nm reached approx. 
0.8. Isopropyl-13-D-thiogalactoside was added to a final concentration 
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of 0.75 mM and cell growth was continued for 15-18 h. Recombinant 
enzymes were isolated from these cultures and purified according to 
previously published procedures [10]. The purity of each final prepara- 
tion was assessed by SDS-polyacrylamide gel electrophoresis. 
2.3. Enzyme assay and kinetic analysis 
HIBADH activity was measured spectrophotometrically as pre- 
viously described [3]. Production of NADH was measured by absorb- 
ance at 340 nm in a Cary 1E spectrophotometer. HIBA, NAD + and 
NADP + concentrations were measured as described previously [3]. 
Bisubstrate kinetic parameters were calculated using the computer 
program of Cleland [11]. 
2.4. Chemical modification 
Purified HIBADH (0.5 mg) was treated with 5 mM pyridoxal phos- 
phate in the presence or absence of 2.5 mM NaBHaCN at room 
temperature in a buffer consisting of 20 mM Tris-HC1, pH 8.0, 250 
mM NaC1, and 5 mM 2-mercaptoethanol. Reaction mixtures and 
stock reagents were protected from light with aluminum foil. At var- 
ious times as indicated, samples were withdrawn and immediately 
used to determine HIBADH activity in previously mixed assay cu- 
vettes. Control samples were incubated under identical conditions. To 
determine the reversibility of the inactivation, samples were dialyzed 
for 15 h at 4°C and in the dark in the above buffer. 
2.5. CD spectrapolarimetry 
CD spectra were recorded at 21°C with a Jasco J-720 spectrapo- 
larimeter. Enzyme concentrations were in the range of 80-100 gg/ml 
with a cell path length of 0.1 cm and a wavelength range of 300-190 
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nm. Secondary structure contents were calculated using the reference 
spectra of Yang et al. [12] and the SSE-338 program (Japan Spectro- 
scopic Co., Tokyo, Japan). 
2.6. Other methods 
Protein concentrations were determined using the Bradford protein 
assay [13] with bovine serum albumin as standard. SDS-polyacryl- 
amide gel electrophoresis was performed according to the method of 
Laemmli [14]. 
3. Results and discussion 
3.1. Amino acid sequence homology 
The H IBADHs of  both rat and P. aeruginosa display sig- 
nificant homology to 6-phosphogluconate dehydrogenase 
throughout their entire amino acid sequences. Fig. 1 shows 
an alignment of  the H IBADH sequences and 5 hypothetical, 
bacterial proteins (unidentified ORFs)  with the sequences of  
6-phosphogluconate dehydrogenase from sheep, S. cerevisiae, 
and E. coli. Also shown is the N-terminal sequence of  a spe- 
cific D-phenylserine dehydrogenase purified from P. syringae 
[15]. Pairwise alignments indicate a range from 21%, for HI- 
BADH vs. 6-phosphogluconate dehydrogenase, to over 70% 
identity with different combinations of  these sequences. HI- 
BADH shares somewhat higher homology with the bacterial 
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Fig. 1. Amino acid sequence comparison of HIBADH with D-phenylserine dehydrogenase, 6-phosphogluconate dehydrogenase, and five hy- 
pothetical bacterial proteins. All sequences were obtained from NCBI databases and alignments were performed using the NCBI BLAST net- 
work service by the method of Altschul et al. [18]. Residues conserved in 50% or more of the sequences are shown with reversed text. PSDH 
(PS) indicates D-phenylserine dehydrogenase from Pseudomonas syringae. HIBADH (PA) and HIBADH (RN) denote 3-hydroxyisobutyrate de- 
hydrogenases from Pseudomonas aeruginosa nd Rattus norvegicus, respectively. PGDH (EC), PGDH (SH), and PGDH (SC) indicate 6-phos- 
phogluconate dehydrogenase from Escherichia coli, sheep, and Saccharomyces cerevisiae, respectively. Hypothetical proteins are identified by 
Genbank accession umbers. SS, EC, and HI indicate Synechocystis sp., Escherichia coli, and Haemophilus influenzae, respectively. 
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Table 1 
Kinetic parameters of wild-type and mutant HIBADH a 
265 
Enzyme Vm~ (units/mg) Ka (p.M) kc~tlK~ (mM -1 s -1) Kb (~tM) kcat/Kb (mM -1 s -1) 
NAD + 
Wild-type 11.0 + 0.8 22 + 6 625 + 110 56 + 7 240 + 30 
D33R 0.7+0.1 1240+ 110 0.70+0.08 112+9 7.9+0.7 
N177Q 0.40 +_ 0.03 55 + 6 9 + 1 890 + 70 0.60 + 0.05 
NADP + 
Wild-type 3.0 + 0.4 960 + 90 4 + 1 104 + 14 38 + 5 
D33R 2.0 + 0.2 240 + 60 10 + 2 110 + 12 22 + 3 
N177Q - - 
aValues are mean + S.D. for three determinations. Dashes indicate no measurable activity or that he parameter could not be determined. Kaand Kb 
represent the Km values for dinucleotide cofactor and substrate, respectively. 
hypothetical proteins than with 6-phosphogluconate dehydro- 
genase. However, the level of homology between the bacterial 
proteins alone suggests that these sequences most likely do not 
represent a single bacterial enzyme such as HIBADH. HI- 
BADH, as well as each of the hypothetical, bacterial proteins 
are approx. 300 amino acid residues in length; whereas 6- 
phosphogluconate dehydrogenases from various species range 
in size from 468 to 482 residues. The D-phenylserine d hydro- 
genase was reported to be a dimer of identical, 31 kDa sub- 
units, similar to the size and subunit composition of HI- 
BADH [2,15]. The C-terminal third of the 6-phospho- 
gluconate dehydrogenases (not shown in Fig. 1) comprises a
domain absent from the other related enzymes and this do- 
main exists in the reported crystal structure as a 'tail' which 
makes specific contacts with the phosphate moiety of 6-phos- 
phogluconate, a part of the substrate absent in HIBA and 
phenylserine. Many of the most highly conserved residues 
are alanines and glycines which probably have important 
structural roles; however, several hydrophobic and polar re- 
sidues, including two lysines and one glutamate, are strictly 
conserved. The N-terminus comprises one of the most highly 
conserved regions in all of these enzymes and shows a strict 
consensus equence, (MG)XXGL(MG)XMGXsNX4G. This 
sequence is typical of the dinucleotide cofactor-binding fold 
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Fig. 2. Inactivation of HIBADH by pyridoxal phosphate. Recombi- 
nant HIBADH was treated with pyridoxal phosphate as described 
in Section 2. Closed symbols indicate nzyme treated with pyridoxal 
phosphate in the presence of sodium cyanoborohydride. Open sym- 
bols indicate nzyme treated with the reducing agent alone. 
of many dehydrogenases, and this region of 6-phosphogluco- 
nate dehydrogenase i  known to comprise the cofactor-bind- 
ing domain from X-ray crystallographic data [9]. However, it 
differs slightly from the consensus sequenses found in other 
enzyme families such as the short-chain dehydrogenases [16]. 
Several other residues which have been implicated in substrate 
binding and catalysis in 6-phosphogluconate dehydrogenase 
also appear to be strictly conserved in this entire family of 
enzymes. These residues include Val-123, Ser-124, Gly-125, 
Gly-126, Lys-173, and Asn-177 (numbered according to rat 
HIBADH). 
3.2. Site-directed mutagenesis 
One of the most crucial residues in the cofactor-binding 
domain of dehydrogenases in general is a charged residue 
located approx. 18-20 residues C-terminal to the conserved 
GXGXXG motif which is preceded by several conserved hy- 
drophobic residues [17]. An acidic residue such as aspartate at 
this position usually provides tringent specificity for NAD + 
whereas a basic residue such as arginine ndows pecificity for 
NADP ÷. All of the published sequences for 6-phosphogluco- 
nate dehydrogenase, an NADP+-specific enzyme, show an 
asparagine and an adjacent arginine at this position, and the 
crystal structure showed that this arginine is involved in bind- 
ing NADP + [9]. HIBADH has an aspartate residue at this 
position, and is specific for NAD ÷. To unambiguously loca- 
lize this domain as the cofactor-binding domain of HIBADH, 
aspartate 33 was substituted with arginine. As shown in Table 
1, this mutation produced a 56-fold increase in Km (NAD +) 
and a 900-fold decrease in koat/Km (NAD+), whereas Km 
(NADP--) actually decreased by 4-fold compared to wild- 
type. Therefore, the D33R mutation produced an enzyme 
with a grossly decreased catalytic efficiency with NAD ÷, but 
with a reversal of the preference for NAD + vs. NADP +. The 
crystallographic studies of sheep 6-phosphogluconate dehy- 
drogenase also suggested that two important catalytic residues 
may be Lys-183 and Asn-187 (K173 and N177 in HIBADH). 
In the 6-phosphogluconate dehydrogenase-substrate cocrystal 
structure these two residues made hydrogen bonds to the 3- 
hydroxyl group of the substrate [9]. A mechanism was pro- 
posed whereby the asparagine r sidue acts as the donor in the 
hydrogen bond to the 3-hydroxyl, and the 3-hydroxyl acts as 
the donor in the hydrogen bond to the lysine residue. This 
lysine residue was proposed to act as a base catalyst. The level 
of homology seen with these residues in the presently reported 
enzymes uggested the possibility of a common mechanism. 
To test this mechanistic proposal, Lys-173 was substituted 
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Table 2 
3-Hydroxyacid substrate specificity of HIBADH ~ 
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Substrate Km Vmax (units/mg) kcJKm (mM -1 s -1) 
S-HIBA 59 + 6 gM 10.3 + 0.9 215 + 22 
R-HIBA 1.5 + 0.1 mM 0.9 + 0.1 0.89 +_ 0.06 
L-Glycerate 9.8 + 0.8 mM 8.0 _+ 1.0 1.06 -+ 0.09 
L-Serine 21 _+ l mM 10.5_ + 1.2 0.64_+0.10 
S-3-Hydroxybutyrate - - 
L-Mevalonate - - 
aValues are mean + S.D. for three determinations. Dashes indicate no measurable activity or that the parameter could not be determined. 
with alanine, arginine, asparagine, and histidine, and Asn-177 
was substituted with glutamine. Each of the Lys-173 mutants 
was well expressed and purified without apparent proteolysis. 
However, each of these mutations produced inactive nzymes, 
even when assayed at very high protein concentrations, high 
concentrations of substrate, and various conditions of pH. 
Each of the Lys-173 mutant enzymes displayed circular di- 
chroism spectra identical to that of wild-type nzyme, suggest- 
ing that no large changes in secondary structure or assembly 
of the enzymes resulted from these mutations. Thus, Lys-173 
appears to play a crucial role in catalysis by HIBADH. Sub- 
stitution of Ash-177 with gtutamine produced an enzyme 
which retained catalytic activity, but displayed a 27-fold de- 
crease in Vm~, and a 16-fold decrease in Km (HIBA) (Table 
1), but no change in Km (NAD÷), consistent with the pre- 
viously proposed catalytic role for this conserved residue in- 
volving a specific interaction with the 3-hydroxyl group of the 
substrate. 
3.3. L ysine-specific chemical modification 
Previous studies utilizing chemical modification of HI- 
BADH showed the enzyme to be sensitive to chemical modi- 
fiers of cysteine and tyrosine [3]. We now report that recom- 
binant rat HIBADH is also readily inactivated by treatment 
with pyridoxal phosphate. In the presence of 5 mM pyridoxal 
phosphate and 2.5 mM NaBH3CN, at 25°C, the inactivation 
occurs with a first order rate constant of 0.05 min -1 (Fig. 2), 
and is irreversible upon extended ialysis, suggesting the for- 
mation of a stable Schiff base with a lysine residue. Treatment 
with pyridoxal phosphate in the presence and absence of co- 
factor and substrates howed significant protection against 
inactivation in the presence of saturating concentrations of 
either R- or S-HIBA, both of which are active substrates, 
but virtually no protection in the presence of NAD +. In light 
of this finding it is interesting to note that the crystal struc- 
tures of 6-phosphogluconate dehydrogenase in the presence 
and absence of bound cofactor indicated a rigid structure 
with no change in conformation upon cofactor binding [9]. 
The present data are consistent with the presence of a lysine 
residue, such as Lys-173, in the active site of rat HIBADH 
which may be involved in substrate binding although other 
lysine residues may be modified and could possibly contribute 
to inactivation of the enzyme. 
3.4. Substrate specificity 
3-Hydroxyisobutyrate, 6-phosphogluconate, and phenylser- 
ine have in common only the 3-hydroxyacid functionality, 
suggesting that this may be a common feature of the substrate 
specificity of the presently proposed family of enzymes. Pre- 
viously, rabbit and rat HIBADH were reported to be specific 
for S-HIBA and R-HIBA though with approx. 20-fold in- 
creased Km for the R enantiomer. Several microbial isozymes 
of HIBADH were reported to be also specific for HIBA but 
with differences in the enantiomeric specificity [5]. Further 
analysis of the substrate specificity of rat HIBADH indicated 
that the enzyme is active with a series of 3-hydroxyacid sub- 
strates including S- and R-HIBA, L-glycerate, and L-serine. 
The Vm~, with most of these substrates was approximately the 
same, however, the Km increased with inqreasing polarity of 
the substituent on the 2-carbon (Table 21. The enzyme was 
inactive with similar compounds containing carbon backbones 
of four or five carbons in length (Table ~ 2). Therefore, the 
optimal substrate can be defined as an L or S-3-hydroxyacid 
with a three-carbon backbone and a nonpolar substituent 
such as a methyl group on the 2-carbon. Substrate specificity 
studies of the bacterial D-phenylserine d hydrogenase also in- 
dicated that only 3-hydroxyacids (in this case, D-3-hydroxy- 
amino acids) could serve as active substrates for this enzyme 
[15]. It is interesting to note that the majority of the sequences 
reported in the present study are of microbial origin, and may 
represent enzymes with particular importance in bacterial bio- 
chemistry. One of the bacterial ORFs (32782 from Haemophi- 
lus influenzae) was reported to be present on an operon in- 
duced by glyoxylate, and one of the enzymes common to the 
glyoxylate cycle of plants and bacteria, tartronate semialde- 
hyde reductase, catalyzes a reaction very similar to that of 
HIBADH: 
CH2OHCH2OHCOO- + NAD + 
CHOCH~OHCOO- + NADH + H-- 
However, identification of this sequence as that of tartro- 
nate semialdehyde r ductase is merely speculative at this time. 
Although several of these sequences remain as unidentified 
open reading frames, we propose that these homologous pro- 
teins represent a distinct family of enzymes most likely con- 
sisting of 3-hydroxyacid dehydrogenases. 
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